Medical research and diagnostic innovation are at the heart of improving patient outcomes, early detection of disease, and the future of healthcare in the UK. From developing new diagnostic tools and laboratory techniques to advancing medical testing technologies, the life sciences and healthcare sectors are pushing the boundaries of medical knowledge and technology every day.
However, moving from medical research to clinically viable solutions is rarely straightforward. Whether you’re working on molecular diagnostics, medical imaging, AI-assisted screening tools, or laboratory process improvements, your business may be overcoming scientific or technological uncertainties — making you eligible for R&D tax relief.
At BC&A, we understand the specific challenges faced by medical research companies and diagnostic technology developers. That’s why we provide specialist support through Kumar Associates, our dedicated medical and healthcare accountancy arm. We help UK businesses in the life sciences sector navigate R&D tax relief claims with confidence.
Here are some examples of qualifying activities in medical research and diagnostics:
Developing New Diagnostic Tests or Screening Methods
Researching and developing laboratory-based or point-of-care tests for early detection of diseases, including genetic testing, biomarker identification, or molecular diagnostics.
Improving Sensitivity, Specificity, or Speed of Diagnostics
Engineering methods to enhance the accuracy, speed, or reliability of existing diagnostic tests, particularly when balancing false positives and negatives is a technical challenge.
Advancing Medical Imaging or Data Interpretation Tools
Developing AI-powered tools, imaging software, or data analytics platforms that support clinicians in detecting, classifying, or monitoring diseases.
Engineering Portable or Remote Diagnostic Devices
Designing devices that allow diagnostic testing to be carried out at the point of care, in remote locations, or outside of traditional healthcare settings, particularly when overcoming size, power, or connectivity limitations.
Enhancing Sample Collection, Preparation, or Handling Processes
Improving laboratory workflows, reagents, or sample preservation techniques to ensure accurate and repeatable test results.
Meeting Clinical Validation and Regulatory Requirements
Developing testing methods or products that comply with UK medical device regulations, such as UKCA marking, particularly when this requires extensive clinical validation or technical iteration.
Integrating Diagnostics with Healthcare Systems or Data Platforms
Overcoming technical challenges in connecting diagnostic tools with electronic health records (EHRs), laboratory information management systems (LIMS), or secure data storage platforms.
Developing Novel Treatment Monitoring or Predictive Tools
Creating diagnostic technologies that monitor treatment effectiveness or predict disease progression, improving personalised care and clinical decision-making.
If your business is involved in advancing medical research or developing new diagnostic technologies, you could be eligible for R&D tax relief. BC&A and Kumar Associates are here to help you unlock the full value of your innovation, supporting the development of life-changing medical technologies for patients in the UK and beyond.